openPR Logo
Press release

End Stage Renal Disease Treatment market size at USD 81330 million by 2029 with a CAGR of 5.2% during 2023-2029

04-15-2024 03:45 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Quants and Trends

End Stage Renal Disease Treatment market

End Stage Renal Disease Treatment market

The global End Stage Renal Disease Treatment market size was valued at USD 56940 million in 2022 and is forecast to a readjusted size of USD 81330 million by 2029 with a CAGR of 5.2% during review period. The global End Stage Renal Disease (ESRD) Treatment Market is witnessing significant growth and development, driven by advancements in healthcare technologies, rising prevalence of chronic kidney diseases, and increasing investments in research and development. According to a recent market analysis, the ESRD treatment market is expected to reach substantial figures in the coming years, indicating a positive trajectory for stakeholders across the healthcare industry.

Market Overview:
The End Stage Renal Disease (ESRD) Treatment Market refers to the healthcare sector focused on providing therapeutic interventions and management solutions for patients suffering from advanced kidney failure. This market encompasses a range of treatment modalities including dialysis, kidney transplantation, pharmaceutical interventions, and supportive care services.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.

Market Key Players:
• Fresenius
• DaVita
• Baxter
• Nipro
• B. Braun
• Asahi Kasei
• Nikkiso
• WEGO
• Newsol
• Mayo Clinic
• Guangdong Biolight
• Medtronic
• Sanxin Medtec
• Jafron Biomedical
• SWS Hemodialysis Care
• Tianyi Medical

GET FREE SAMPLE REPORT PDF @ https://quantsandtrends.com/form/request-for-free-sample-pdf?report_code=HC2343&nid=1980

Market Segmentation by Type:
• Hemodialysis
• Peritoneal Dialysis
• Kidney Transplantation

Market Segmentation by Application:
• Hospitals
• Kidney Dialysis Centers
• At Homes
• Others

Regional Markets:

• US Market: The United States accounts for a significant portion of the global ESRD treatment market, driven by a high prevalence of chronic kidney diseases, advanced healthcare infrastructure, and favorable reimbursement policies.
• Europe Market: Europe represents another key region in the ESRD treatment market, characterized by robust healthcare systems, increasing investments in research, and a growing geriatric population.
• APAC Market: The Asia-Pacific region is witnessing rapid growth in the ESRD treatment market, fueled by improving healthcare infrastructure, rising awareness about kidney diseases, and expanding access to treatment options.
• Middle-East Market: The Middle East region is emerging as a lucrative market for ESRD treatment, with growing investments in healthcare infrastructure, rising incidence of lifestyle-related diseases, and expanding dialysis facilities.

Market Segmentation by Regions:
• North America (United States, Canada, and Mexico)
• Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
• South America (Brazil, Argentina and Rest of South America)
• Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

For Exhaustive Table of Contents and Tables and Figures, please visit @ https://quantsandtrends.com/End-Stage-Renal-Disease-Treatment-Market

Market Strengths:
• Increasing prevalence of chronic kidney diseases.
• Advancements in dialysis technology and transplantation procedures.
• Rising investments in research and development.
• Favorable reimbursement policies in key markets.

Market Weaknesses:
• High treatment costs associated with dialysis and transplantation.
• Limited availability of donor organs for transplantation.
• Challenges related to patient adherence to treatment regimens.

Market Opportunities:
• Emerging markets in Asia-Pacific and Latin America.
• Development of innovative pharmaceutical interventions.
• Adoption of telemedicine and remote monitoring solutions.
• Collaborations between healthcare providers and technology companies.

Market Threats:
• Stringent regulatory requirements for drug approvals.
• Competition from alternative therapies such as regenerative medicine.
• Economic uncertainties impacting healthcare spending.
• Shortage of skilled healthcare professionals.

Market Past Performance:
Historical data indicates steady growth in the ESRD treatment market over the past decade, driven by increasing incidence of kidney diseases, advancements in medical technology, and expanding access to healthcare services.

Market Forecast:
Future projections suggest sustained growth in the ESRD treatment market. Factors such as aging populations, rising prevalence of diabetes and hypertension, and technological innovations are anticipated to drive market expansion.

Market Research and Development:
Ongoing research and development efforts focus on developing novel treatment modalities, improving patient outcomes, and enhancing the efficiency of healthcare delivery systems. Key areas of R&D investment include bioartificial kidneys, wearable dialysis devices, and precision medicine approaches.

Market PESTEL Analysis:
A PESTEL analysis of the ESRD treatment market highlights the impact of political, economic, social, technological, environmental, and legal factors on market dynamics. These factors influence market growth, regulatory frameworks, and investment decisions.

Market SIPOC Analysis:
A SIPOC analysis (Suppliers, Inputs, Processes, Outputs, Customers) provides insights into the value chain of the ESRD treatment market, identifying key stakeholders, operational processes, and customer requirements. This analysis aids in streamlining processes, enhancing efficiency, and improving overall market performance.

Conclusion:
The End Stage Renal Disease (ESRD) Treatment Market presents significant growth opportunities for stakeholders across the healthcare industry. With increasing investments in research and development, advancements in medical technology, and expanding access to healthcare services, the market is poised for sustained growth in the coming years. By addressing key challenges, capitalizing on emerging trends, and fostering collaborations, stakeholders can contribute to improving patient outcomes and driving innovation within the ESRD treatment landscape.

For further inquiries, please contact:
info@quantsandtrends.com
US: +1-315-675-4303
INDIA: +91-952-980-3362
Sector-13, Chikhali Pradhikaran,
Pune-411019, Maharashtra, India.
https://quantsandtrends.com/

About Quants and Trends:
Through our consulting research solutions, we guide our clients in discovering answers to their research needs. We pledge to offer our clients only the best research and consulting services. With our low-cost market research services, we assist our clients in understanding the major industry trends, spotting opportunities, and coming to wise conclusions. We understand not every client's particular research needs may be satisfied by syndicated papers. We offer our dear clients with an array of options to tailor research to meet their unique objectives and financial constraints.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release End Stage Renal Disease Treatment market size at USD 81330 million by 2029 with a CAGR of 5.2% during 2023-2029 here

News-ID: 3464465 • Views:

More Releases from Quants and Trends

Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8.2% during review period 2023-2029
Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8. …
The global Shape Memory Alloys Market size was valued at USD 796.4 million in 2022 and is forecast to a readjusted size of USD 1385.4 million by 2029 with a CAGR of 8.2% during review period. Market Overview: Shape Memory Alloys (SMAs) are revolutionary materials with the unique ability to return to a predetermined shape when subjected to certain stimuli, such as temperature or stress. This remarkable property has led to their
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% during review period 2023-2029
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% du …
The global Electroless Plating Market size was valued at USD 4457.4 million in 2022 and is forecast to a readjusted size of USD 5469.7 million by 2029 with a CAGR of 3.0% during review period. Market Overview: Electroless plating, also known as autocatalytic plating, is a chemical process that deposits a metal or alloy onto a substrate without the use of an external electrical power source. This method offers several advantages, including
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during review period 2023-2029
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during revi …
The global Braze Market size was valued at USD 4904 million in 2022 and is forecast to a readjusted size of USD 5563.3 million by 2029 with a CAGR of 1.8% during review period. Market Overview: The Braze Market plays a pivotal role in various industries, offering a reliable method for joining metal components with superior strength and durability. Brazing involves the use of a filler metal that melts above 450°C (840°F)
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a CAGR of 3.2% during review period 2023-2029
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a C …
The global Re-dispersible Latex Powder (RDP) Market size was valued at USD 1556.8 million in 2022 and is forecast to a readjusted size of USD 1935.3 million by 2029 with a CAGR of 3.2% during review period. Market Overview: Re-dispersible latex powder (RDP) is a crucial additive used in construction materials such as mortars, plasters, and tile adhesives. It enhances the performance of these materials by imparting properties such as improved adhesion,

All 5 Releases


More Releases for ESRD

End Stage Renal Disease (ESRD) Drug Market to advance a Potential Growth of 12.5 …
End Stage Renal Disease (ESRD) Drug Market report with its market research studies help anticipate next move of the competitors while keeping business in a better position to avert any possible damage from their end. Market research can help identify markets and geographical areas where business can expand to. It can also help to invest in ideas that have the most potential to succeed based on what customers are looking
Dialysis Scheduling Software Market Insights by 2027 & Covid-19 Analysis | MIQS, …
This Dialysis Scheduling Software market report focuses on market share, size, competition level, key pricing structure and major key developments in the market. It further goes on with concentrating on financial requirements as well as investments. Some market strategies are discussed here for generating huge revenues through business. It further guides about how to track the business growth. New patented technologies and productions processes are also mentioned here to help
A Billion dollar ($11.9 billion) boom in Erythropoietin Drugs Market due to ca …
Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of erythropoiesis (production of red blood cells). This erythropoietin (EPO) drugs are used for the treatment of chemotherapy-induced anemia; anemia is a common side-effect occurring due to chemotherapy of End Stage Renal Diseases (ESRD), cancer and HIV. Improved recombinant DNA technology has led to the development of synthetic forms of erythropoietin such as epoetin
Dialysis Continues to Remain Dominant Therapy to Treat ESRD
Patients with end-stage renal disease (ESRD) currently have two treatment options – kidney transplant and dialysis. The limited number of kidney donors worldwide and the various medical complications that arise from dialysis have pushed the medical fraternity to look for suitable alternatives to treat ESRD. Implantable bio artificial kidneys are the latest innovation in healthcare science that provide the health benefits of kidney transplantation and potentially wipe out the need
End-Stage Renal Disease (ESRD) Drugs – Qualtitative and Qualtitative Market Re …
Qyresearchreports include new market research report “Global End-Stage Renal Disease (ESRD) Drugs Market Professional Survey Report 2017” to its huge collection of research reports. A market intelligence report on the global market for End-Stage Renal Disease (ESRD) Drugs has been added to enable key stakeholders in it to bet right on the market and thus improve their profit margins. The exhaustive report furnishes information on how the market for End-Stage Renal
Global End Stage Renal Disease (ESRD) Development Market with Focus on Dialysis …
"Global End Stage Renal Disease (ESRD) Market with Focus on Dialysis Market (2017-2021 Edition)" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '